About Avant Sante
Avant Santé Research Center S.A. de C.V. is a Contract Research Organization headquartered in Monterrey, Mexico providing a broad breadth of services that include Clinical Pharmacology, Pharmacokinetics and Biostatistics, Bioanalytics, Clinical Trials, Pharmacovigilance support, Quality Control and Product Managment.
Advantages
-
Avant Santé has strategic agreements with central COVID-19 centers appointed by the Government of Mexico, allowing rapid enrollment of patients. This provides faster human trials for our ARDVIR two-drug combination before starting multi-center trials elsewhere.
-
Services well known drug companies providing FDA trial support.
-
Offers integrated regulatory and clinical development strategy and services to FDA requirements.
-
Have completed a number of COVID-19 human trials in Mexico: Rapid protocol approval by regulatory (within 24 hours), rapid initiation of trials at sites and rapid recruitment of patients.
-
Conducting a study in Mexico enables COFEPRIS (Mexico FDA) to issue registration before US FDA/EMA. Trial data from Mexico trials will be to FDA standards.
-
The lead time between Clinical Trial completion and Market authorization in Mexico could be as little as 6 months.
-
Is a shareholder of Artin Biosciences
-
As part of their investment is providing scientific and pharmacological staff on loan adding to the strength of our team.
Avant Santé is a French term that means “A step forward in Health” represents in addition to a desire for good health in the personal, a movement and a continuous effort without delay in actions that seek to improve health, is also an effort towards The improvement, in a “well being”.